Journal of Biomedical Materials Research Part B Applied Biomaterials · 2013 · 47 citations · 26 references
MedicineDental Biomaterials SciencePeriodonticsBone GraftingCanine DentistryTissue EngineeringBiomaterials For Oral RegenerationBone Graft MaterialsBone Graft SubstitutesBone RegenerationBone Tissue EngineeringOsteogenesisBone Regeneration BiomaterialsDental Implant BiomaterialsDental ImplantsDental Mesenchymal Stem CellsHydroxyapatiteIntrabony DefectsPorous HydroxyapatiteRegenerate Bone Formation
Tissue engineering has been applied to overcome the obstacles encountered with bone regeneration for the placement of dental implants. The purpose of this study was to determine the bone formation ability of human bone marrow-derived mesenchymal stem cells (BMMSCs) and platelet-rich plasma (PRP) when applied separately or together to the intrabony defect around dental implants with a porous hydroxyapatite (HA) scaffold. Standardized three-wall intrabony defects (4 × 4 × 4 mm) were created at the mesial of each dental implant site in four mongrel dogs. Defects were then grafted with the following materials: HA + BMMSCs (HS group), HA + PRP (HP group), HA + BMMSCs + PRP (HSP group), and HA scaffold alone (HA group). The level of bone formation (bone density) and osseointegration (bone-to-implant contact [BIC]) in bone defects around the implants were evaluated by histological and histometric analysis at 6 and 12 weeks after the placement of implants. HA, HS, HP, and HSP groups generally showed an increase in bone density and BIC between 6 and 12 weeks, except BIC in the HS group. Although no statistically significant differences were found among HA, HS, HP, and HSP groups (p > 0.05), the highest level of bone density and BIC were observed in the HSP group after the 12-week healing period. Furthermore, the level of bone maturation was higher in the HSP group than in the other groups as determined histologically. The findings of this preliminary study suggest that BMMSCs and PRP combined with HA scaffold may provide additional therapeutic effects on bone regeneration and improve osseointegration in bone defects around dental implants.
26
Robert E. Marx, Eric R. Carlson, Ralph M. Eichstaedt et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 1998 · 2.6K citations
Medicine, Hematology, Bone Grafting +16
Morbidity at Bone Graft Donor Sites
Edward M. Younger, Michael W. Chapman · Journal of Orthopaedic Trauma · 1989 · 2K citations
Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?
Robert E. Marx · Implant Dentistry · 2001 · 1.7K citations
Characterization of cells with osteogenic potential from human marrow
Stephen E. Haynesworth, J. Goshima, Valentin Goldberg et al. · Bone · 1992 · 1.3K citations